Physicians

Department / Division
Surgery / Urology

Address
DUMC 2812
Durham, NC 27710

Appointment Telephone
919-684-2446

Office Telephone
919-681-8760

Fax Telephone
919-684-5220

Training

• MD, University of Alberta (Canada), 2000

Residency

• Urology, Laval University (Canada), 2005

Fellowship

• Urologic Oncology, Mayo Clinic (Minnesota), 2008

Other Training

• Fellow, Royal College of Surgeons of Canada, 2005
• MSc, Mayo Clinic (Minnesota), 2011

Clinical Interests
Bladder cancer (including bladder-sparing options, robotic cystectomy, neobladders, hyperthermia); penile cancer (including penis-sparing options and inguinal lymphadenectomy); kidney cancer (including minimally-invasive surgery, partial nephrectomy and vena caval thrombectomy); testicular cancer; urachal cancer; cancers of the ureter and renal pelvis; advanced genitourinary cancer surgery (including masses invading multiple organs and treatment-refractory tumors)

Research Interests
Clinical research interests:
Health economics, cancer screening, prognostic modeling, cancer clinical trials, and the issues surrounding cancer survivorship.

Basic science research interests:
Tumor immunology, immune therapies for cancer, molecular biology of bladder cancer.

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Bristol-Myers Squibb
• GlaxoSmithKline

Representative Publications
Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008 May;53(5):976-81. (2008) Abstract

Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, Karnes RJ, Leibovich BC. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level >/=50 ng/mL. Cancer. 2008 Oct 1;113(7):1544-51. (2008) Abstract

Inman BA, Frigola X, Harris KJ, Kuntz SM, Lohse CM, Leibovich BC, Kwon ED. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol. 2008 Mar 1;180(5):3578-84. (2008) Abstract

Inman BA, Myers RP. Is the location of a positive surgical margin after radical prostatectomy important for prognosis? Nat Clin Pract Urol. 2008 Sep;5(9):476-7. (2008) Abstract

Magera JS Jr, Inman BA, Slezak JM, Bagniewski SM, Sebo TJ, Myers RP. Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy. J Urol. 2008 Jan;179(1):130-5. (2008) Abstract

Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008 Jul;180(1):306-11; discussion 311. (2008) Abstract

Routh JC, Inman BA, Ashley RA, Vandersteen DR, Reinberg Y, Wolpert JJ, Kramer SA, Husmann DA. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux? J Pediatr Urol. 2008 Aug;4(4):260-4. (2008) Abstract

Routh JC, Inman BA, Reinberg Y. Re: Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. W. H. Cerwinka, H. C. Scherz and A. J. Kirsch. J Urol 2007; 178: 1469-1473. J Urol. 2008 Mar;179(3):1205; author reply 1205. (2008) Abstract

Routh JC, Kramer SA, Inman BA, Ashley RA, Wolpert JJ, Vandersteen DR, Husmann DA, Reinberg Y. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies. Urology. 2008 Mar;71(3):435-8. (2008) Abstract

Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU Int. 2008 Jan;101(2):170-4. (2008) Abstract

Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol. 2008 May;179(5):1830-7; discussion 1837. (2008) Abstract

Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, Gettman MT, Blute ML. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007 Oct 15;110(8):1708-14. (2007) Abstract

Ashley RA, Inman BA, Routh JC, Rohlinger AL, Husmann DA, Kramer SA. Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol. 2007 Oct;178(4 Pt 2):1615-8. (2007) Abstract

Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007 Dec;70(6):1064-8. (2007) Abstract

Inman BA, Frigola X, Dong H, Kwon ED. Costimulation, coinhibition and cancer. Curr Cancer Drug Targets. 2007 Feb;7(1):15-30. (2007) Abstract

Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007 Apr 15;109(8):1499-505. (2007) Abstract

Magera JS Jr, Inman BA, Elliott DS. Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement? J Urol. 2007 Oct;178(4 Pt 1):1328-32; discussion 1332. (2007) Abstract

Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res. 2007 Aug 15;67(16):7893-900. (2007) Abstract

Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol. 2007 Oct;178(4 Pt 2):1702-5; discussion 1705-6. (2007) Abstract

Webster WS, Thompson RH, Harris KJ, Frigola X, Kuntz S, Inman BA, Dong H. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J Immunol. 2007 Sep 1;179(5):2860-9. (2007) Abstract

Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006 Aug 15;107(4):712-20. (2006) Abstract

Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, Blute ML, Zincke H. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006 Sep;68(3):604-8. (2006) Abstract

Inman BA, Myers RP. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006. J Urol. 2006 Sep;176(3):1252-3; author reply 1253. (2006) Abstract

Inman BA. Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol. 2006 May;175(5):1960; author reply 1960-1. (2006) Abstract

Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer. 2006 Aug 1;107(3):521-9. (2006) Abstract

Inman BA, Harel F, Audet JF, Meyer F, Douville P, Fradet Y, Lacombe L. Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival. Eur Urol. 2005 May;47(5):695-702. (2005) Abstract

Inman BA, Harel F, Tiguert R, Lacombe L, Fradet Y. Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients. J Urol. 2003 Nov;170(5):1888-91. (2003) Abstract

Inman B, Halloran B, Melk A, Ramassar V, Halloran PF. Microchimerism in sensitized renal patients. Transplantation. 1999 May 27;67(10):1381-3. (1999) Abstract